Unknown PHASE3 INTERVENTIONAL 2-arm NCT05618223

Dapagliflozin Effect on Rheumatic Mitral Stenosis (Dapa-Rhemis)

Sponsor: Universitas Sebelas Maret

Conditions Heart Failure Mitral Stenosis Rheumatic Heart Disease

Updated 4 times since 2022 Last updated: Nov 16, 2022 Started: Dec 1, 2022 Primary completion: May 31, 2023 Completion: Jun 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Heart Failure and Mitral Stenosis and is currently ongoing. Universitas Sebelas Maret leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Dec 2024 — Present [monthly]

Unknown PHASE3

Status: Not Yet Recruiting → Unknown
Sep 2024 — Dec 2024 [monthly]

Not Yet Recruiting PHASE3
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE3
Dec 2022 — Jul 2024 [monthly]

Not Yet Recruiting PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universitas Sebelas Maret

Data source: Universitas Sebelas Maret

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Sukoharjo, Indonesia